- China Biotech In Review: SciClone Pharma In-Licenses China Rights To Heart Failure Drug
- China Biotech In Review: Sagent Buys Out China JV Partner For $25 Million
- Teva's CEO Thinks China Is A 'Natural Fit'
- China Biotech In Review: Chindex Buys Israeli Laser Company For $240 Million
- China Biotech In Review: WuXi PharmaTech Contributes To Syros Pharma Funding
ChinaBio Today
ChinaBio Today
Stop FollowingChinaBio Today
ABOUT
China has become the #2 pharmaceutical market years ahead of projections and continues to be the fastest growing market in the world. China is $50 billion dollars a year into life science and healthcare development through over 160 government funding programs. VC investment, M&A transactions and cross-border partnering deals in China were all up significantly in 2012.
ChinaBio® Today focuses exclusively on the rapidly evolving life science industry in China, including biotech, pharma, medical device, diagnostics, services and tools. From our offices in Shanghai and San Diego, our industry analysts provide daily news, commentary and analysis on public and private China life science companies, as well as ...More events and global issues affecting the China market.
Visit: ChinaBio Today (http://www.chinabiotoday.com)
ChinaBio LLC (http://www.chinabiollc.com)
ChinaBio® Today focuses exclusively on the rapidly evolving life science industry in China, including biotech, pharma, medical device, diagnostics, services and tools. From our offices in Shanghai and San Diego, our industry analysts provide daily news, commentary and analysis on public and private China life science companies, as well as ...More events and global issues affecting the China market.
Visit: ChinaBio Today (http://www.chinabiotoday.com)
ChinaBio LLC (http://www.chinabiollc.com)
SNAPSHOT
- Description: Investment banker – boutique firm. Trading frequency: Not Trading
- Interests: Foreign stocks
COMPANY
ChinaBio LLC ChinaBio® has established a broad platform of capabilities connecting global life science with China. As the foremost experts on the China life science industry, we have helped many large, multinational corporations as well as China domestic companies achieve success in China. We focus on consulting, ...More
advisory services, conferences, and information (newsletter, reports and databases).
Consulting
f you are a Western life science company looking to establish relationships or operations in China, ChinaBio® has the expertise and talent to help.
• China strategy development
• Market assessment
• Competitive analysis
• Technology and partner searches
• Market entry services & support
• Mergers & Acquisitions
• Corporate Financing
• Government Funding
Conferences
ChinaBio® organizes the premier life science investment and partnering conferences in China. We also work with key partners to organize custom events in China, the U.S . and Europe.
• ChinaBio® Partnering Forum
• ChinaBio® Investor Forums
• ChinaBio® Executive Retreat
• Customized Events
Information
ChinaBio® Today, with over 18,000 subscribers, is the most widely read publication on China's life science industry. ChinaBio also maintains the broadest and most comprehensive knowledgebase on the industry, including over 1000 partnering, VC, M&A and IPO transactions.
Please visit our websites or contact us for more information on how ChinaBio can help your company achieve success in China.
www.chinabiollc.com
www.chinabiotoday.com
+86-21-5137-0751
+1-858-926-4566
Shanghai |San Diego
BLOG
ChinaBio® Today
ChinaBio Today - Focused solely on China life science... China is the fastest growing market in the world for pharmaceuticals. Now, after billions of dollars of investment, China is transforming itself into a world leader in life sciences. ChinaBio® Today focuses exclusively on the rapidly evolving life ...More
science industry in China. From our offices in Shanghai and San Diego, we provide daily news, commentary and analysis on public and private China life science companies and industry events, as well as global issues affecting the China life science market.
Book
Currently, there are no book details for ChinaBio Today.
Latest comments on ChinaBio's Articles
- 6228371 on Teva's CEO Thinks China Is A 'Natural Fit'
- Sanvisor on Teva's CEO Thinks China Is A 'Natural Fit'
- eforman on China Biotech In Review: Cellular Biomedicine T...
- hugochazez on China Biotech In Review: 2012 China Life Scienc...
- buccaneer 1961 on China Biotech In Review: 2012 China Life Scienc...
LATEST ARTICLES & INSTAPOSTS
more »


